Deliver Your News to the World

Medtronic to Showcase Latest Aortic Repair Technology at International Vascular Surgery Meeting in New York


Following an unprecedented year of advances in the field of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), will showcase at the international VEITHsymposium™ its recently-expanded portfolio and robust pipeline of stent grafts and delivery systems, including:

* Talent™ Abdominal and Thoracic Stent Grafts
* Xcelerant® and Xcelerant Hydro Delivery Systems

Recently approved by the U.S. Food and Drug Administration (FDA), the Talent Stent Grafts expand the indications for EVAR and thereby are expected to allow physicians to treat more patients. The Xcelerant Delivery Systems enable improved deliverability and controlled deployment for accurate stent graft placement within the aorta.

“These advances both aid physicians and expand the number of patients with aortic aneurysms that they are able to treat,” said Tony Semedo, vice president and general manager of Endovascular Innovations at Medtronic.

“We remain committed to extending our legacy of leadership by continuing to provide more advanced EVAR products so that no patient is denied the benefits of a minimally-invasive option for aortic repair.”

The 35th annual VEITHsymposium™ takes place Nov. 19–23 at the New York Hilton. Numerous scientific sessions reporting the latest data on Medtronic’s aortic repair technology will be supported by key events at the Medtronic pavilion:

* Luncheon symposia on recent advancements in EVAR:
o Abdominal / Thursday, 11:45 a.m. – 1 p.m., featuring Prof. Piergiorgio Cao, University of Perugia and Dr. William Jordan, University of Alabama at Birmingham
o Thoracic / Friday, 11:45 a.m. – 1 p.m., featuring Drs. Karthikeshwar Kasirajan, Emory University; Rossella Fattori, University Hospital of Bologna; and Ronald Fairman, University of Pennsylvania
* Meet-the-expert sessions:
o Dr. Manish Mehta, Albany Medical Center Hospital / Thursday, 10:30 – 11:15 a.m.
o Dr. Frank Criado, Union Memorial Hospital / Thursday, 2:30 – 3:15 p.m.
o Dr. Frank Arko, Southwestern Medical Center / Thursday, 4 – 4:45 p.m.
o Dr. Luis Sanchez, Washington University School of Medicine / Friday, 9:15 – 10 a.m.
o Prof. Piergiorgio Cao, University of Perugia / Friday, 11 – 11:45 a.m.
o Dr. Venkatesh Ramaiah, Arizona Heart Institute / Friday, 4 – 4:45p.m.

As the pioneer of endovascular therapy for aortic aneurysms, Medtronic has been an innovator and leader in the stent graft industry for more than a decade. Its long history includes more than 150,000 patients treated with stent grafts dating back to 1995. Medtronic currently offers the broadest portfolio of aortic stent grafts. These include the AneuRx AAAdvantage® and Talent Abdominal Stent Grafts with the Xcelerant Hydro Delivery System, the Talent Thoracic Stent Graft with the Xcelerant Delivery System, as well as the Reliant® Stent Graft Balloon Catheter.

Now in its fourth decade, VEITHsymposium ( provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique opportunity to access the latest information on the treatment of vascular disease.


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.